Abbott | ABT - Zinsaufwendungen Für Schuld

Aktienkurs
102.73
Täglich Wechseln
-0.83 -0.80%
Monatlich
-7.07%
Jährlich
-17.49%
Q2 Prognose
99.77




Zinsaufwendungen Für Schuld Veränderung Datum
Abbott USD 42M 2M 2025-12
Agilent USD 25M 2M 2025-12
AtriCure USD 1.33M 17K 2025-09
Baxter International USD 58M 14M 2025-09
Becton, Dickinson and Co. USD 153M 2M 2025-12
Bio-Rad Laboratories USD 12.3M 100K 2025-09
Boston Scientific USD 90M 3M 2025-12
Cooper Companies USD 22.4M 2M 2025-12
Danaher USD 55M 12M 2025-12
Dexcom USD 4.7M 0 2025-09
Edwards Lifesciences USD 38.6M 1.2M 2025-09
Globus Medical USD 17K 5.1B 2025-12
Hologic USD 27.6M 1000K 2025-12
Insulet USD 9.2M 2.2M 2025-12
Integra LifeSciences USD 23.67M 953K 2025-12
Intuitive Surgical USD 19.35B 811.4M 2025-09
J&J USD 18M 290M 2025-09
Masimo USD 7.5M 1.3M 2025-12
Medtronic USD 181M 0 2025-12
Merit Medical Systems USD 6.36M 390K 2025-12
Pfizer USD 711M 59M 2025-12
Smith & Nephew USD 69M 1000K 2025-12
Solventum Corp USD 51M 13.92B 2025-12
Stryker USD 157M 46.17B 2025-09
Tandem Diabetes Care USD 2.07M 872.58M 2025-12
Teleflex USD 28.15M 3.69M 2025-12
Terumo JPY 463M 445M 2025-12
Thermo Fisher Scientific USD 365M 18M 2025-12
Zimmer Biomet Holdings USD 71.9M 3.5M 2025-12